Top

Israel Journal of Health Policy Research

Published in:

Open Access 01-12-2016 | Commentary

Decision making about infertility treatment: does unlimited access lead to inappropriate treatment?

Author: Evan R. Myers

Published in: Israel Journal of Health Policy Research | Issue 1/2016

Abstract

The proportion of women aged 40–44 undergoing IVF treatment covered by Maccabi Health Services increased between 2011 and 2014. Although age-specific birth rates did not substantially change over this time period, the demographic change was accompanied by an overall decrease in live births after IVF treatment. The relative contribution of changing population demographics vs. current age-related coverage policies to these trends is unclear. Additional research is needed to better understand the potential effect of changes in current policy on maternal, neonatal, and economic outcomes.

Schneider D. The Great Recession, Fertility, and Uncertainty: Evidence From the United States. J Marriage Fam. 2015;77:1144–56.CrossRef

Cohen A, Dehejia R, Romanov D. Financial incentives and fertility. Rev Econ Stat. 2013;95:1–20.CrossRef

Ebenstein A, Hazan M, Simhon A. Changing the Cost of Children and Fertility: Evidence from the Israeli Kibbutz. Econ J. 2015. http://onlinelibrary.wiley.com/doi/10.1111/ecoj.12240/full

Bitler MP, Schmidt L. Utilization of infertility treatments: the effects of insurance mandates. Demography. 2012;49:125–49.CrossRefPubMed

Hamilton BH, McManus B. The effects of insurance mandates on choices and outcomes in infertility treatment markets. Health Econ. 2012;21:994–1016.CrossRefPubMed

Kiatpongsan S, Huckman RS, Hornstein MD. The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States. Fertil Steril. 2015 Feb;103(2):448–54.

Gleicher N, Kushnir VA, Weghofer A, Barad DH. The “graying” of infertility services: an impending revolution nobody is ready for. Reprod Biol Endocrinol. 2014;12:63.CrossRefPubMedPubMedCentral

Kawwass JF, Monsour M, Crawford S, et al. Trends and outcomes for donor oocyte cycles in the United States, 2000–2010. JAMA. 2013;310:2426–34.PubMedPubMedCentral

Kol S, Yellin LB, Segal Y, Porath A. In vitro fertilization (IVF) treatments in Maccabi Healthcare Services 2007–2014. Isr J Health Policy Res. 2016;5:14.CrossRefPubMedPubMedCentral

10.

Myers ER. Repeated In Vitro Fertilization Cycles for Infertility. JAMA. 2015;314:2627–9.CrossRefPubMed

Title: Decision making about infertility treatment: does unlimited access lead to inappropriate treatment?
Author: Evan R. Myers
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Israel Journal of Health Policy Research / Issue 1/2016
Electronic ISSN: 2045-4015
DOI: https://doi.org/10.1186/s13584-016-0083-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Decision making about infertility treatment: does unlimited access lead to inappropriate treatment?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors

Social characteristics associated with disparities in smoking rates in Israel

Vaccine hesitancy as self-determination: an Israeli perspective

Between individualism and social solidarity in vaccination policy: the case of the 2013 OPV campaign in Israel

The IJHPR celebrates five years of quality publication

Physician-facilitated designation of proxy decision maker